- ►annals.org [PDF] A Fritsche, MA Schweitzer, HU Haring… - Annals of internal medicine, 2003 - Am Coll Physicians Glimepiride Combined with Morning Insulin Glargine, Bedtime Neutral ...
Protamine Hagedorn Insulin, or Bedtime Insulin Glargine in Patients ... Andreas
Fritsche, MD; Matthias Axel Schweitzer, MD; Hans-Ulrich Häring, MD; and ... Cited by 158 - Related articles - BL Direct - All 7 versions
AN Goudswaard, NJ Furlong, GE Rutten, RP … - Cochrane Database Syst Rev, 2004 - igitur-archive.library.uu.nl This is a reprint of a Cochrane review, prepared and maintained by The Cochrane
Collaboration and published in The Cochrane Library 2006, Issue 2 ... Insulin
monotherapy versus combinations of insulin with oral hypoglycaemic agents ... Cited by 42 - Related articles - View as HTML - All 8 versions
J Hänninen, J Takala, S Keinänen- … - Diabetes research and clinical practice, 2001 - Elsevier Some features of diabetes care and diabetes treatment regimen which may have an
impact on health-related quality of life (HRQOL) in people with diabetes were
studied cross-sectionally using the SF-20 questionnaire. Of the 381 ... Cited by 39 - Related articles - All 7 versions
BP Kovatchev, WL Clarke, M Breton, K … - Diabetes Technology & Therapeutics, 2005 - liebertonline.com BORIS P. KOVATCHEV, Ph.D., WILLIAM L. CLARKE, MD, MARC BRETON, Ph.D., KENNETH
BRAYMAN, MD, and ANTHONY MCCALL, MD, Ph.D. ... Background: Continuous glucose
monitors (CGMs) collect detailed blood glucose (BG) time series, which ... Cited by 38 - Related articles - BL Direct - All 3 versions
- ►nih.gov [PDF] WJ De Grauw, EH Van de Lisdonk, WH Van … - The British Journal of General Practice, 2001 - pubmedcentral.nih.gov Introduction THE life expectancy and quality of life of type 2 diabetic patients
is reduced by the long term complications of this chronic disease, in particular
cardiovascular morbidity.1,2 The United Kingdom prospective diabetes study ... Cited by 36 - Related articles - BL Direct - All 6 versions
TME Davis, RM Clifford, WA Davis - Diabetes research and clinical practice, 2001 - Elsevier Previous studies investigating the relationship between insulin therapy on
quality of life (QOL) in Type 2 diabetes have produced conflicting results that
may reflect differences in patient samples, study design and context. To ... Cited by 35 - Related articles - All 7 versions
DW Brown, LS Balluz, WH Giles, GL Beckles, … - Diabetes research and clinical practice, 2004 - Elsevier The aim of the present study was to examine associations between the presence of
diabetes mellitus and health-related quality of life (HRQOL) among older adults.
Using data from 37,054 adults aged 50 years or older who participated in ... Cited by 34 - Related articles - All 9 versions
M Davies - International journal of obesity, 2004 - nature.com The benefits of good glycaemic control in both type I and type II diabetes
mellitus are undoubtedly proven. Most national bodies have recommended glycaemic
targets, with an HbA 1c to achieve between 6.5 and 7.5%. However, it is ... Cited by 30 - Related articles - BL Direct - All 6 versions
C Carver - The Diabetes Educator, 2006 - tde.sagepub.com Insulin therapy has been shown to benefit the prognosis in patients with type 2
diabetes, but its initiation and intensification is often delayed through
concerns about hypoglycemia and weight gain. In addition, weight gain is ... Cited by 27 - Related articles - BL Direct - All 3 versions
AN Goudswaard, MDRP Stolk, P Zuithoff, HW … - J Fam Pract, 2004 - jfponline.com Consider adding bedtime NPH insulin to maximal oral therapy—a simple, safe,
and well-tolerated regimen that lowers HbA 1c on average by 1 percentage point. ... Expect this regimen to fail for about 25% of patients within 1 year. Cited by 27 - Related articles - Cached - BL Direct - All 4 versions
